CAS 72332-33-3: Procaterol
Formula:C16H22N2O3
InChI:InChI=1/C16H22N2O3/c1-4-12(17-9(2)3)16(21)11-5-7-13(19)15-10(11)6-8-14(20)18-15/h5-9,12,16-17,19,21H,4H2,1-3H3,(H,18,20)/t12-,16+/s2
InChI key:InChIKey=FKNXQNWAXFXVNW-ZEFNCDPZNA-N
SMILES:[C@H]([C@H](NC(C)C)CC)(O)C1=C2C(=C(O)C=C1)NC(=O)C=C2
Synonyms:- (.+-.)-Procaterol
- (R,S)-Procaterol
- 2(1H)-Quinolinone, 8-hydroxy-5-[1-hydroxy-2-[(1-methylethyl)amino]butyl]-, (R*,S*)-
- rel-8-Hydroxy-5-[(1R,2S)-1-hydroxy-2-[(1-methylethyl)amino]butyl]-2(1H)-quinolinone
- 2(1H)-Quinolinone, 8-hydroxy-5-[(1R,2S)-1-hydroxy-2-[(1-methylethyl)amino]butyl]-, rel-
Sort by
Found 4 products.
Procaterol
CAS:Procaterol is a bronchodilator, which is a synthetic beta-2 adrenergic agonist. It is derived through chemical processes designed to specifically target the beta-2 adrenergic receptors located in the bronchial smooth muscle. The mode of action involves the activation of these receptors, which leads to the relaxation of bronchial smooth muscles. This relaxation effect facilitates the widening of airways, improving airflow and respiratory function. Procaterol is primarily used in the management of obstructive pulmonary disorders, such as asthma and chronic obstructive pulmonary disease (COPD). By easing bronchial constriction, it alleviates symptoms such as shortness of breath, wheezing, and coughing, thus enhancing patient respiratory comfort and overall quality of life. The drug's pharmacological design ensures that it acts rapidly, making it an effective solution for acute relief of bronchospasm. Procaterol's specificity for beta-2 receptors reduces the risk of cardiac side effects, a crucial consideration in the treatment of chronic respiratory conditions.Formula:C16H22N2O3Purity:Min. 95%Molecular weight:290.36 g/mol
